Furthermore, it has been reported that MMP2 and MMP9 are differentially expressed in patients with minimal change disease, focal segmental glomerulosclerosis and membranous nephropathy [41, 42]. This evidence concerns the gene MMP9 and focal segmental glomerulosclerosis.